Francis Kwame Morgan Tetteh

Mr. Francis Kwame Morgan Tetteh

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2022 in African Journal of Laboratory Medicine
Verified
Journal Article
Open access
SASeth Attoh
Seth Attoh
FTFrancis Kwame Morgan Tetteh
Francis Kwame Morgan Tetteh
MMMary McAddy
Mary McAddy
KAKingsley Ackah
Kingsley Ackah
RKRichmond Kyei
Richmond Kyei
RFRaymond D. Fatchu
Raymond D. Fatchu
Background: Accreditation is important for all medical laboratories, particularly public health laboratories in developing countries. Several laboratories in Ghana implemented the requirements of the International Organization for Standardization (ISO) 15189 but were unable to proceed to accreditation. This article describes the challenges faced by the Pathology Division Laboratory of the 37 Military Hospital, Accra, Ghana, during the acquisition of ISO 15189 accreditation and suggests solutions for a better approach.Intervention: Following ISO 15189 accreditation in 2017, an online survey was conducted between 01 and 30 March 2020 among the laboratory staff. Respondents were required to grade, on a scale of 0 (least) to 5 (most), the extent to which 16 key challenges influenced the process of obtaining accreditation. Key informant interviews were also held with laboratory personnel who were directly involved in the establishment of the quality management system in the laboratory and the accreditation acquisition process.Lessons learnt: Documentation, laboratory safety measures, laboratory management support, and reagent unavailability were estimated as the challenges that most affected the acquisition of laboratory accreditation. Challenges such as poor communication, staff apathy and workload had the least effect on the accreditation process. There was no difference in challenges identified between persons who worked in the laboratory before or after accreditation (p = 0.11).Recommendations: To surmount the anticipated challenges, there is the need for national strategic direction for laboratory accreditation, hospital and laboratory management support for the accreditation acquisition and maintenance processes, and sufficient technical assistance in the form of training and mentorship.

5 April 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FTFrancis Kwame Morgan Tetteh
Francis Kwame Morgan Tetteh
AAAnthony Ablordey
Anthony Ablordey
NONoah Obeng-Nkrumah
Noah Obeng-Nkrumah
JOJapheth Awuletey Opintan
Japheth Awuletey Opintan
Introduction: Extended-spectrum beta-lactamase (ESBL)-producingEscherichia coliandKlebsiella pneumoniaeare pathogens of significant public health interest for which new antibiotics are urgently needed.Aim: To determine the prevalence of ESBLs inE.coliandK.pneumoniaeisolates from patients attending the Tamale Teaching Hospital (TTH) in Ghana.Methodology: The study was a cross-sectional study involving convenience sampling ofE.coliandK.pneumoniaeisolates from consenting patients’ clinical specimens, between April and June 2015. Antimicrobial susceptibility test was performed, and ESBL-producer phenotypes were further screened forBlaTEM,BlaSHV, andBlaCTX-Mgenes. Patients’ clinical data were additionally collected using a structured questionnaire.Results: Of the 150 non-duplicateE.coliandK.pneumoniaeisolates identified, 140 were confirmed asE.coli(84%,n= 117) andK.pneumoniae(16%,n= 23). Of these, sixty-two (44%) [E.coli(84%;n= 52);K.pneumoniae(16%;n= 10)] phenotypically expressed ESBLs. The proportion of ESBL-producing isolates was higher in adults (15–65 years) than in neonates (< 28 days) (p =0.14). Most of the isolates showed a high percentage resistance to ampicillin (96%) and tetracycline (89%), but a relatively lower resistance to amikacin (36%). No isolate was resistant to meropenem. More ESBL producers were multidrug resistant compared to non-ESBL-producers [23% (14/62) versus 18% (14/78);p= 0.573]. Overall, 74% (n= 46) of the ESBL genotypes expressedBlaCTX-M-1genes, followed by 63% (n= 39)BlaTEM, and 16% (n= 10)BlaSHV. The study showed a high prevalence of ESBL-positiveE.coliandK.pneumoniae, mostly CTX-M-1 producers at TTH.Conclusion: Routine laboratory ESBL screening is warranted to inform patient management.

FTFrancis Kwame Morgan Tetteh
Francis Kwame Morgan Tetteh
RFRaymond Fatchu
Raymond Fatchu
KAKingsley Ackah
Kingsley Ackah
TPTRUDY JANICE PHILIPS
TRUDY JANICE PHILIPS
HSHemant Deepak Shewade
Hemant Deepak Shewade
EAEmmanuel Parbie Abbeyquaye
Emmanuel Parbie Abbeyquaye
In this study, we described the bacterial profile, antibiotic resistance pattern, and laboratory result turnaround time (TAT) in neonates with suspected sepsis from a tertiary-level, military hospital in Accra, Ghana (2017–2020). This was a cross-sectional study using secondary data from electronic medical records. Of 471 neonates clinically diagnosed with suspected sepsis in whom blood samples were collected, the median TAT from culture request to report was three days for neonates who were culture-positive and five days for neonates who were culture-negative. There were 241 (51%) neonates discharged before the receipt of culture reports, and of them, 37 (15%) were culture-positive. Of 471 neonates, twenty-nine percent (n = 139) were bacteriologically confirmed, of whom 61% (n = 85) had late-onset sepsis. Gram-positive bacterial infection (89%, n = 124) was the most common cause of culture-positive neonatal sepsis. The most frequent Gram-positive pathogen was coagulase-negative Staphylococcus (55%, n = 68) followed by Staphylococcus aureus (36%, n = 45), of which one in two were multidrug resistant. The reasons for large numbers being discharged before the receipt of culture reports need to be further explored. There is a need for improved infection prevention and control, along with ongoing local antimicrobial resistance surveillance and antibiotic stewardship to guide future empirical treatment.

11 September 2025 in Microbiology Resource Announcements
Verified
Journal Article
Open access
FTFrancis Kwame Morgan Tetteh
Francis Kwame Morgan Tetteh
BEBeverly Egyir
Beverly Egyir
WBWilliam Boateng
William Boateng
COChristian Owusu-Nyantakyi
Christian Owusu-Nyantakyi
JDJustice Kwesi Danso
Justice Kwesi Danso
Kwabena Obeng DueduKwabena Obeng Duedu
Kwabena Obeng Duedu
Bloodstream infection and neonatal sepsis pose a significant public health threat in sub-Saharan Africa. To support drug discovery, surveillance, and vaccine development prospects, genomic data on resistance are needed. We present a draft genome and antibiogram of a multidrug-resistant Klebsiella pneumoniae- ST152 strain KA017_S253, recovered from a neonate.

11 May 2026 in Wellcome Open Research
Verified
Journal Article
Open access
AFArmelle Forrer
Armelle Forrer
HKHenry Kajumbula
Henry Kajumbula
ENEdward O. Nyarko
Edward O. Nyarko
IBImmaculate Barasa
Immaculate Barasa
MOMoses Odhiambo
Moses Odhiambo
NFNicholas Feasey
Nicholas Feasey
Background Healthcare-associated infections (HAIs) significantly contribute to patient morbidity and mortality worldwide, particularly in sub-Saharan Africa (sSA), where prevalence rates range between 6.7% and 28%. HAI are particularly associated with extensive antimicrobial resistance (AMR), which may potentially render HAI untreatable in settings with poor access to Watch and Reserve antibiotics. Methods This observational cohort study, conducted across hospitals in Kenya, Ghana, Malawi, and Uganda, aimed to estimate antimicrobial resistance (AMR) rates in HAIs, describe clinical outcomes, and assess hospital length of stay (LoS) among hospitalized patients with HAIs. Kaplan Meir plots were used to explore the impact of treatment adequacy on survival rate for different HAIs. Mixed-effect logistic regression models were used to assess the impact of drug resistance or treatment inadequacy on odds of survival. Results Of 336 participants enrolled between October 2021 and January 2023, 207 had at least one positive microbiological test, contributing 244 isolates. The highest AMR prevalence was observed in the Enterobacterales family, Staphylococcus aureus , and Acinetobacter spp. of which 85.3% (116/136), 78.6% (11/14) and 72.7% (16/22) exhibited AMR, respectively. Over 80.9% (114/141) of pathogenic isolates were either 3GC-R or MDR and 88.6% of those (101/114) were both MDR and 3GC-R. There was a 16.7% case fatality rate, with inadequate or unknown adequacy of antimicrobial treatment significantly associated with increased odds of death in patients with bloodstream infection, hospital acquired pneumonia or complicated skin and soft tissue infection (OR 2.90, 95% CI 0.99–8.36). Increased odds of death were also associated with hospital stay in an ICU ward (OR 4.70, 95%CI 1.80–12.32) and with increasing years of age (OR 1.01, 95%CI 1.01–1.04). Conclusion The findings highlight the urgent need for local treatment guidelines, improved infection prevention and control measures, and antimicrobial stewardship in sSA to reduce the burden of AMR and improve patient outcomes.

12 March 2026 in Research Square
Verified
Preprint
Open access
PDF file
FTFrancis Kwame Morgan Tetteh
Francis Kwame Morgan Tetteh
WBWilliam Boateng
William Boateng
MOMary-Madgalene Osei
Mary-Madgalene Osei
FKFleischer C. N. Kotey
Fleischer C. N. Kotey
BDBismark Dabuo
Bismark Dabuo
EDEric Donkor
Eric Donkor
Antibiotic-resistant Klebsiella pneumoniae presents a significant global health threat, prompting urgent calls for new treatment options. This study determined antibiotic resistance profiles of K. pneumoniae isolates from blood cultures in Southern Ghana and characterized the β-lactamase enzymes mediating β-lactam resistance. Archived K. pneumoniae isolates stored at -80°C at the Department of Medical Microbiology, University of Ghana Medical School were retrieved and revived for the study. Isolate identities were confirmed using the BD Bruker MALDI-TOF. Antimicrobial susceptibility testing was performed using both the MicroScan AutoSCAN system and Kirby-Bauer disc diffusion method. Of the 109 non-duplicate archived isolates, 95 (87.2%) were confirmed as K. pneumoniae . All confirmed isolates exhibited resistance to at least one antibiotic class, with two isolates (2.1%) resistant to all tested antibiotics. High resistance rates were observed for trimethoprim-sulfamethoxazole (85.3%), gentamicin (83.2%), ceftriaxone (80.0%), cefotaxime (78.9%), and ceftazidime (77.9%). Resistance to ertapenem (18.9%), and meropenem (8.4%) was comparatively lower. β-Lactamase enzyme profiles revealed that 77.9% (n = 74/95) of screened isolates were extended-spectrum beta-lactamase (ESBL) producers, 51.6% (n = 47/91) were AmpC producers, 26.6% (n = 17/64) were carbapenemase-producers, and 12.5% (n = 6/48) exhibited resistance to colistin. Notably, 12.5% of isolates concurrently produced ESBL, AmpC, and carbapenemase enzymes and were resistant to colistin. The prevalence of ESBL-producing K. pneumoniae was higher among children under five years of age compared to adults over sixty, though the difference was not statistically significant ( p = 0.933). All ESBL-producing isolates were multidrug-resistant (MDR), and 76.2% (n = 21) of non-ESBL producers were also MDR. AmpC-producing isolates were significantly more prevalent among children under five than among those aged 5–19 and adults over sixty ( p = 0.023). The high prevalence of MDR K. pneumoniae strains producing ESBLs, AmpCs, carbapenemases, and exhibiting colistin resistance is alarming and significantly narrows treatment options for bloodstream infections. These findings highlight the urgent need for alternative therapeutic strategies and routine surveillance to guide effective clinical management and antimicrobial stewardship.